T2 Biosystems Inc Quick Ratio (TTOO) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


T2 Biosystems Inc   (NASDAQ: TTOO)

T2 Biosystems Inc 's Quick Ratio

TTOO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2024, Quick Ratio fell to 0.09 a new company low.

Within Medical Equipment & Supplies industry 218 other companies have achieved higher Quick Ratio than T2 Biosystems Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 2929 to 4728.

Explain Quick Ratio?
How much Cash & cash equivalents TTOO´s has?
What are TTOO´s Current Liabilities?




TTOO Quick Ratio (Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
Y / Y Current Liabilities Change -55.94 % -67 % 215.53 % 402.39 % 414.42 %
Y / Y Cash & cash equivalent Change -91.43 % -73.6 % -38.64 % 51.89 % 19.41 %
Quick Ratio MRQ 0.09 0.19 0.11 0.28 0.44
TTOO's Total Ranking # 4728 # 2929 # 3350 # 0 # 2468
Seq. Current Liabilities Change 12.09 % -61.25 % 0.19 % 1.26 % -16.05 %
Seq. Cash & cash equivalent Change -50.94 % -31.6 % -60.43 % -35.49 % 51.2 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 219
Healthcare Sector # 1087
Overall Market # 4728


Quick Ratio Statistics
High Average Low
14.29 3.52 0.09
(Dec 31 2014)   (Sep 30 2024)




Financial Statements
T2 Biosystems Inc 's Current Liabilities $ 24 Millions Visit TTOO's Balance sheet
T2 Biosystems Inc 's Cash & cash equivalent $ 2 Millions Visit TTOO's Balance sheet
Source of TTOO's Sales Visit TTOO's Sales by Geography


Cumulative T2 Biosystems Inc 's Quick Ratio

TTOO's Quick Ratio for the trailling 12 Months

TTOO Quick Ratio

(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 5.4 % 79.19 % 342.73 % 312.94 % 226.07 %
Y / Y Cash & cash equivalent TTM Growth -53.61 % -11.31 % 15.32 % 4.61 % -28.59 %
Quick Ratio TTM 0.18 0.27 0.27 0.34 0.4
Total Ranking TTM # 4080 # 3459 # 3474 # 0 # 3995
Seq. Current Liabilities TTM Growth -16.36 % -18.92 % 19.66 % 29.88 % 42.21 %
Seq. Cash & cash equivalent TTM Growth -44.06 % -19 % -5.9 % 8.81 % 6.95 %


On the trailing twelve months basis In spite of the year on year decrease in TTOO's Current Liabilities to $24.44 millions, cumulative Quick Ratio to 0.18 below the TTOO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 214 other companies have achieved higher Quick Ratio than T2 Biosystems Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 3459 to 4080.

Explain Quick Ratio?
How much Cash & cash equivalents TTOO´s has?
What are TTOO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 215
Healthcare Sector # 1005
Within the Market # 4080


trailing twelve months Quick Ratio Statistics
High Average Low
5.85 2.22 0.18
(Sep 30 2017)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Medical Equipment & Supplies Industry Quick RatioSep 30 2024 MRQ Cash & cash equivalentSep 30 2024 MRQ Current Liabilities
Baxter International Inc   0.23 $ 1,420.000  Millions$ 6,200.000  Millions
Steris Plc  0.22 $ 172.195  Millions$ 774.974  Millions
Ufp Technologies Inc   0.21 $ 16.356  Millions$ 78.347  Millions
Stevanato Group S p a   0.21 $ 110.062  Millions$ 534.771  Millions
Bioventus Inc   0.20 $ 43.074  Millions$ 211.492  Millions
Encision Inc   0.20 $ 0.230  Millions$ 1.140  Millions
Dentsply Sirona Inc   0.19 $ 296.000  Millions$ 1,542.000  Millions
National Vision Holdings Inc   0.19 $ 81.154  Millions$ 426.123  Millions
Orthofix Medical Inc   0.19 $ 30.054  Millions$ 161.898  Millions
Bausch and Lomb Corp  0.18 $ 329.000  Millions$ 1,801.000  Millions
Integer Holdings Corporation  0.17 $ 35.574  Millions$ 213.515  Millions
Venus Concept Inc   0.16 $ 4.489  Millions$ 27.467  Millions
Zimmer Biomet Holdings Inc   0.16 $ 569.000  Millions$ 3,571.300  Millions
P3 Health Partners Inc   0.16 $ 62.962  Millions$ 405.318  Millions
The Cooper Companies Inc   0.12 $ 107.600  Millions$ 892.900  Millions
Precision Optics Corporation Inc   0.12 $ 0.636  Millions$ 5.336  Millions
Patterson Companies Inc   0.12 $ 157.935  Millions$ 1,344.436  Millions
Biolase Inc   0.12 $ 3.444  Millions$ 29.422  Millions
Vsee Health Inc   0.12 $ 2.327  Millions$ 20.212  Millions
Neuraxis Inc   0.11 $ 0.281  Millions$ 2.664  Millions
American Oncology Network Inc   0.10 $ 19.432  Millions$ 199.857  Millions
Globus Medical Inc   0.09 $ 71.940  Millions$ 818.065  Millions
Petvivo Holdings Inc   0.09 $ 0.161  Millions$ 1.858  Millions
Baird Medical Investment Holdings Limited  0.09 $ 2.970  Millions$ 34.623  Millions
Escalon Medical Corp   0.09 $ 0.230  Millions$ 2.682  Millions
T2 Biosystems Inc   0.09 $ 2.083  Millions$ 24.435  Millions
Glucotrack Inc   0.08 $ 0.346  Millions$ 4.611  Millions
Interpace Biosciences Inc   0.07 $ 1.400  Millions$ 18.769  Millions
Enovis Corp  0.07 $ 35.425  Millions$ 530.222  Millions
Stimcell Energetics Inc   0.06 $ 0.021  Millions$ 0.318  Millions

Date modified: 2026-08-29T17:26:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.